Cargando…
Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions
BACKGROUND: The ‘placebo effect’ and ‘nocebo effect’ are phenomena whereby beneficial (placebo) or adverse (nocebo) effects result from the expectation that an inert substance will relieve or cause a particular symptom. These terms are often inappropriately applied to effects experienced on drug the...
Autores principales: | Penson, Peter E., Mancini, G. B. John, Toth, Peter P., Martin, Seth S., Watts, Gerald F., Sahebkar, Amirhossein, Mikhailidis, Dimitri P., Banach, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240752/ https://www.ncbi.nlm.nih.gov/pubmed/30311434 http://dx.doi.org/10.1002/jcsm.12344 |
Ejemplares similares
-
Statins as anti-pyroptotic agents
por: Khalifeh, Masoomeh, et al.
Publicado: (2021) -
Drucebo effect – the challenge we should all definitely face!
por: Banach, Maciej, et al.
Publicado: (2021) -
Prevalence of statin intolerance: a meta-analysis( )
por: Bytyçi, Ibadete, et al.
Publicado: (2022) -
Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone
por: Ganjali, Shiva, et al.
Publicado: (2020) -
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
por: Penson, Peter E., et al.
Publicado: (2022)